top of page

Home > Specialists > Neurology > Dr. Ligang Song (宋立刚)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Neurointerventional specialist at Beijing Tiantan Hospital in Beijing, focused on ischemic cerebrovascular disease, cerebral aneurysms, cerebrovascular stenosis and occlusion, and endovascular revascularization procedures.

Professional Title & Qualifications:

  • Associate Chief Physician,

  • Associate Professor,

  • M.D. in Neurology

Hospital & Department:

Beijing Tiantan Hospital, Capital Medical University – Department of Interventional Neurology, Cerebrovascular Disease Center

(address: No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070)

Dr. Ligang Song (宋立刚) - Interventional Neurologist Specialist

Personal Biography

Dr. Ligang Song is an Associate Chief Physician and Associate Professor in the Department of Interventional Neurology at Beijing Tiantan Hospital’s Cerebrovascular Disease Center. As a Clinical Group Leader, he has nearly 20 years of clinical, research and teaching experience in neurointerventional therapies for ischemic cerebrovascular disease. His background includes a 2012 visiting scholar position at UCLA Medical Center, alongside ongoing research in stroke intervention and cerebrovascular hemodynamics.

Why Choose Dr. Ligang Song for Your Care?

Dr. Song’s practice is centered on complex ischemic cerebrovascular disease, cerebral aneurysms and endovascular revascularization procedures. His high annual procedural volume — nearly 1,000 neurointerventional procedures per year — gives international patients a specialist profile to consider when preparing complex imaging, prior treatment history and focused questions for remote specialist review or pre-travel planning.


His work at Beijing Tiantan Hospital, a leading tier-3 neurology institution in China, is supported by multidisciplinary neuroimaging and interventional infrastructure. For patients comparing options before medical travel to China, this background can help frame a more organized records package and specialist-review request.

Pre-Travel Case Review & Specialist Liaison

International travel for neurointerventional care requires careful preparation, especially when diagnostic imaging, prior hospital records and treatment history need to be organized before departure. Through MedBridgeNZ Limited, international patients may request coordination for a remote specialist-review pathway with Dr. Song or the relevant specialist office where available.


MedBridgeNZ supports medical-record organization, translation coordination, client-authorized document transfer and appointment communication so submitted materials are easier to review for appointment triage or preliminary case-screening. If an in-person Beijing pathway is pursued, MedBridgeNZ can also assist with non-clinical logistics, including medical invitation or visa-document coordination support, travel planning, accommodation coordination and non-clinical bilingual administrative support.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Ligang Song

Areas of Expertise

  • Cerebral Aneurysms: Endovascular management of anterior communicating, posterior communicating, ophthalmic, middle cerebral, and vertebrobasilar aneurysms.

  • Cerebrovascular Stenosis and Occlusion: Management and intervention for ischemic conditions.

  • Revascularization: Stenting procedures for the carotid artery, middle cerebral artery, basilar artery, vertebral artery, and subclavian artery.

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

2,500 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • July 2013 – Present: Associate Chief Physician and Associate Professor, Department of Interventional Neurology, Cerebrovascular Disease Center, Beijing Tiantan Hospital.

Education & Training

  • January 2012 – December 2012: Visiting Scholar, University of California, Los Angeles (UCLA) Medical Center, USA.

  • Ph.D. in Neurology, Hebei Medical University.

  • Master's Degree in Pathology and Pathophysiology, Hebei Medical University.

Awards & Honors

  • First Prize, Thrombectomy Competition, Tiantan Cerebrovascular Disease Conference (2017).

  • First Prize, Thrombectomy Competition, Annual Meeting of the Interventional Neurology Branch, Chinese Stroke Association (2018).

  • "Golden Cup Knight" Award, 21st China Cerebrovascular Disease Forum (2024).

Academic & Professional Memberships

  • Committee Member, 1st and 2nd Brain Metabolism and Blood Flow Branch, Chinese Stroke Association.

  • Committee Member, Integrative Medicine Branch, Chinese Stroke Association.

  • Board Member, Interventional Branch, Beijing Medical Doctor Association.

Research & Publications

  • Authored and co-authored extensive academic literature focusing on acute ischemic stroke interventions, stenting efficacy, and hemodynamics.

  • Published research on the safety and efficacy of rapamycin-eluting vertebral stents for symptomatic extracranial vertebral artery stenosis in Frontiers in Neurology (2021).

  • Co-authored studies on transradial approaches using distal access catheters for symptomatic intracranial vertebral and basilar artery stenosis, published in the Journal of NeuroInterventional Surgery (2022).

  • Contributed to multicenter trials evaluating vascular closure devices, published in the Journal of Vascular Access (2023).

Selected Peer-Reviewed Publications

Below is a selection of Dr. Song's highly cited clinical research, demonstrating ongoing leadership in the treatment and diagnostic evaluation of complex conditions:

  • Ma, G., Song, L., et al. (2021). Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis. Frontiers in Neurology. 👉 Read on PubMed (PMID: 34899552)

  • Guo, X., et al. (2022). Transradial approach using a distal access catheter without guiding support for symptomatic intracranial vertebral artery and basilar artery stenosis: a multicenter experience and technical procedure. Journal of NeuroInterventional Surgery. 👉 Read on PubMed (PMID: 34131051)

  • Song, L., et al. (2023). Use of the MynxGrip vascular closure device: The PANDA multicenter, open-label, randomized controlled trial. The Journal of Vascular Access. 👉 Read on PubMed (PMID: 37345318)

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

How can I request a remote specialist review with Dr. Song before deciding whether to travel to China?


MedBridgeNZ can coordinate a remote specialist-review request for international patients where available. Our team helps organize and translate medical records, prepare diagnostic imaging for client-authorized transfer, and communicate with the relevant specialist office for appointment triage or preliminary case-screening. Clinical suitability and next-step medical advice remain with the licensed specialist or hospital.


Does my condition fall under Dr. Song’s area of clinical focus?


Dr. Song’s clinical focus includes endovascular treatment for cerebral aneurysms, cerebrovascular stenosis and occlusion, and revascularization procedures for selected ischemic cerebrovascular conditions. If your diagnosis involves these neurovascular concerns, MedBridgeNZ can help prepare your records and questions for specialist appointment triage where available.


What logistics can MedBridgeNZ coordinate if I pursue care in Beijing?


MedBridgeNZ assists with non-clinical medical travel coordination, including appointment request communication, medical invitation or visa-document coordination support, travel planning, accommodation coordination and non-clinical bilingual administrative support for hospital visits in Beijing. Appointment availability and medical decisions remain with the relevant hospital or licensed specialist.

Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We help with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support in Beijing. We do not provide medical advice, diagnosis or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.

bottom of page